You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SR 142801

Showing 1 - 25 of 544
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

Recruiting
  • Prostate Adenocarcinoma
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023

Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

Recruiting
  • Prostate Adenocarcinoma
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023

Post-menopausal Vasomotor Symptoms Trial in West Bend (ACER-801 50 mg BID, ACER-801 100 mg BID, ACER-801 200 mg BID)

Recruiting
  • Post-menopausal Vasomotor Symptoms
  • ACER-801 50 mg BID
  • +3 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jan 30, 2023

Acute Ischemic Stroke Trial in Barcelona (Thrombectomy)

Recruiting
  • Acute Ischemic Stroke
  • Thrombectomy
  • Barcelona, Spain
    Hospital Universitario Vall d'Hebrón
Nov 18, 2022

Atrial Fibrillation Prior and Post Elective Cardioversion

Not yet recruiting
  • Atrial Fibrillation
  • ECG monitoring prior and after cardioversion
  • (no location specified)
Jun 29, 2023

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Wrinkle, Benign Pigmented Lesion Trial in Waltham (SR-1 Laser)

Active, not recruiting
  • Wrinkle
  • Benign Pigmented Lesion
  • SR-1 Laser
  • Waltham, Massachusetts
    AVAVA, Inc.
Oct 24, 2022

Prostate Cancer Trial in Basel (3D model guided secondary resection)

Completed
  • Prostate Cancer
  • 3D model guided secondary resection
  • Basel, Switzerland
    Universitätsspital Basel Urologie
Jul 17, 2023

Prognostic Factors for Ablation of Atrial Fibrillation

Not yet recruiting
  • Atrial Fibrillation
  • +4 more
  • Catheter ablation
  • (no location specified)
Jan 29, 2023

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

Healthy Volunteer, Renal Impairments Trial in Gyeonggi-do, Seoul (YHD1119 75mg)

Completed
  • Healthy Volunteer
  • Renal Impairments
  • YHD1119 75mg
  • Gyeonggi-do, Korea, Republic of
  • +1 more
Jun 28, 2022

Edentulous Mouth, Dental Prosthesis Failure Trial in Schaan (Examination of dentures with SR Phonares II teeth)

Active, not recruiting
  • Edentulous Mouth
  • Dental Prosthesis Failure
  • Examination of dentures with SR Phonares II teeth
  • Schaan, Liechtenstein
    Ivoclar Vivadent AG
Oct 25, 2022

Cognitive Impairment, Child Autism Trial in Hong Kong (Bicycle learning, Stationary cycling)

Completed
  • Cognitive Impairment
  • Child Autism
  • Bicycle learning
  • Stationary cycling
  • Hong Kong, China, Hong Kong
    EdUHK
Aug 12, 2022

Advanced / Metastatic Solid Tumor Trial (SR-8541A)

Not yet recruiting
  • Advanced / Metastatic Solid Tumor
  • (no location specified)
Oct 3, 2023

Arterial Occlusive Diseases, Intermittent Claudication Trial in Korea, Republic of (Sarpogrelate SR, Sarpogrelate)

Completed
  • Arterial Occlusive Diseases
  • Intermittent Claudication
  • Gangneung-si, Gangwon-do, Korea, Republic of
  • +6 more
Sep 13, 2023

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Basilar Artery Occlusion, Endovascular Treatment Trial in China (Contact aspiration Thrombectomy, Stent retriever thrombectomy)

Recruiting
  • Basilar Artery Occlusion
  • Endovascular Treatment
  • Contact aspiration Thrombectomy
  • Stent retriever thrombectomy
  • Hefei, Anhui, China
  • +5 more
Nov 17, 2022

Study to Evaluate Effects of Concurrent Therapy of Sarpogrelate

Completed
  • Arteriosclerosis Obliterans
  • Busan, Korea, Republic of
    BuKyung Kim
Nov 14, 2022

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Herpes Zoster (HZ), Shingles, Infectious Disease Trial in Hollywood, Tampa, Berlin (JCXH-105, Active Control (Shingrix))

Recruiting
  • Herpes Zoster (HZ)
  • +2 more
  • JCXH-105
  • Active Control (Shingrix)
  • Hollywood, Florida
  • +2 more
May 23, 2023

Malaria Trial in Kampala (Transfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system,

Not yet recruiting
  • Malaria
  • Transfluthrin - delivery by paid study personnel
  • +2 more
  • Kampala, Uganda
  • +1 more
Nov 7, 2023

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Bladder Cancer Trial in Hong Kong (Bipolar transurethral standard resection, Bipolar transurethral en bloc resection)

Completed
  • Bladder Cancer
  • Bipolar transurethral standard resection
  • Bipolar transurethral en bloc resection
  • Hong Kong, Hong Kong
  • +12 more
Jun 24, 2022

Optic Neuritis Trial in London (Fampridine SR)

Recruiting
  • Optic Neuritis
  • Fampridine SR
  • London, Ontario, Canada
    London Health Sciences Centre
Aug 22, 2022